A common virus long associated with mild illness may hold a key to understanding-and ultimately treating-the autoimmune disease lupus.New research published November 12, 2025, in Science Translational medicine suggests the Epstein-Barr virus (EBV) plays a meaningful role in triggering the condition, which affects millions worldwide. The study identifies a specific mechanism by which EBV may reprogram immune cells,offering a potential new target for therapies and renewed hope for those living with this chronic and challenging disease.
Common Virus May Trigger Autoimmune Disease Lupus, New Research Suggests
Table of Contents
A common virus, the Epstein-Barr virus (EBV), may be a key trigger for lupus, a chronic autoimmune disease, according to a groundbreaking study published November 12, 2025, in Science Translational Medicine. The findings offer a potential explanation for the long-understood mystery of what causes lupus and could pave the way for new treatments.
Lupus occurs when the body’s immune system attacks its own tissues and organs. Symptoms can range from skin rashes and joint pain to more serious complications affecting the kidneys, blood, and nervous system. Currently, there is no cure for lupus, and treatment focuses on managing symptoms.
Researchers discovered that EBV, typically a mild illness causing symptoms like sore throat, fever, and swollen tonsils, may lead to immune system dysfunction and the misdirected attack on the body’s own cells. Approximately 95% of people are infected with EBV at some point in their lives, and the virus remains dormant within the body’s cells by inserting its genetic material into DNA, according to NBC News.
The study focused on how EBV interacts with B cells, a crucial part of the immune system responsible for recognizing and binding to proteins on the surface of viruses, known as antigens. EBV can permanently reside in B cells, but approximately 20% of B cells also have the potential to bind to parts of the body’s own cells. In healthy individuals, these “self-reactive” B cells are usually inactive.
Using high-precision gene sequencing, researchers analyzed EBV infection levels and types of B cells in 11 lupus patients and 10 healthy individuals. The analysis revealed a significant difference: healthy participants had fewer than one EBV-infected B cell per 10,000 B cells.
In contrast, lupus patients had approximately one EBV-infected B cell for every 400 B cells – a 25-fold increase compared to the control group. EBV was also more frequently found in the self-reactive B cells. The research suggests EBV reprograms B cells, causing them to produce antibodies that attack the body’s own tissues.
The virus appears to activate these B cells, triggering an autoimmune response and recruiting other immune cells, such as cytotoxic T cells, to join the attack. This finding could explain why lupus develops in some individuals and not others.
Findings Could Lead to New Therapies
“We believe this applies to 100% of lupus cases,” said William Robinson, a professor of immunology and rheumatology at Stanford University and one of the study’s authors, in a report by The Guardian. “This research truly lays the foundation for a new generation of therapies that could fundamentally treat lupus and benefit patients.”
Scientists have long suspected a link between EBV and lupus, but pinpointing the exact connection has been challenging. This new study provides crucial evidence to support that theory. If the link between EBV and lupus is further confirmed, it could accelerate ongoing clinical trials for an EBV vaccine.
According to educational resources from Chimei Hospital, lupus causes the immune system to mistakenly attack healthy cells, leading to inflammation throughout the body, affecting organs like the skin, joints, blood, kidneys, and nervous system.
Several research teams are also exploring the possibility of repurposing cancer therapies that eliminate B cells to treat severe lupus. These developments offer hope for more targeted and effective treatments for this debilitating autoimmune disease.
News Sources
Further Reading
【加入關鍵評論網會員】每天精彩好文直送你的信箱，每週獨享編輯精選、時事精選、藝文週報等特製電子報。還可留言與作者、記者、編輯討論文章內容。立刻點擊免費加入會員！
責任編輯：朱家儀
核稿編輯：楊士範
